ARCHIVES

Avastin Improves PFS In Advanced Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

April 27, 2012

NRC Group Splits Over chemical Dose Testing For Carcinogenicity

March 12, 1993

A Low-Cost Vaccine To Enter Clinical Trials In A Year

September 24, 2010

NCCS Networker Volume 3 Issue 4, Fall 1989

September 13, 1989

UCLA Comp Center status Near, But There Are Problems

October 22, 1976

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

July 26, 2013